{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:44:45Z","timestamp":1761101085167},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T00:00:00Z","timestamp":1326153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Haploidentical hematopoietic stem cell transplantation (HSCT) has been increasingly applied in high\u2010risk hematologic patients due to the absence of HLA\u2010matched donors. The aim of this study was to investigate the efficacy and safety of unmanipulated haploidentical allogeneic peripheral blood stem cells transplantation (PBSCT) for hematologic malignancies.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> Patients who underwent unmanipulated HLA\u2010mismatched\/haploidentical PBSCT from July 2007 to March 2010 with high\u2010risk hematologic malignancies were enrolled for retrospective analysis.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Twenty\u2010one patients with high\u2010risk hematologic malignancies underwent unmanipulated HLA\u2010mismatched\/haploidentical PBSCT with myeloablative conditioning. The numbers of CD34+ cells infused at transplantation were 4.81 (range, 2.61\u201011.47)\u2003\u00d7\u200310<jats:sup>6<\/jats:sup>\/kg. Patients achieved myeloid and platelet engraftment at a median of 16.5 and 20 days, respectively. The cumulative incidence of acute graft\u2010versus\u2010host disease (GVHD) on Day 100 was 52.7\u2003\u00b1\u200310.7%, and the 2\u2010year cumulative incidence of chronic GVHD was 39.5\u2003\u00b1\u200310.6%. The cumulative incidences of cytomegalovirus antigenemia and hemorrhagic cystitis within 100 days after PBSCT were 59.5\u2003\u00b1\u200316.7 and 34.8\u2003\u00b1\u200313.3%, respectively. One hundred\u2010day transplantation\u2010related mortality (TRM) rate and the 2\u2010year cumulative TRM rate were 14.3 and 20.5\u2003\u00b1\u20037.8%, respectively. The 2\u2010year cumulative overall survival was 62.1\u2003\u00b1\u200311.4% and the probability of disease\u2010free survival at 2 years was 55.6\u2003\u00b1\u200310.7% with a 16\u2010month median follow\u2010up.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> Unmanipulated PBSCT is a promising protocol in HLA\u2010mismatched\/haploidentical transplant settings.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2011.03478.x","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T03:24:53Z","timestamp":1326252293000},"page":"1354-1362","source":"Crossref","is-referenced-by-count":20,"title":["Unmanipulated HLA\u2010mismatched\/haploidentical peripheral blood stem cell transplantation for high\u2010risk hematologic malignancies"],"prefix":"10.1111","volume":"52","author":[{"given":"Wenrong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunji","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunshun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,10]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705710"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-1-27"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-0734.2001.00034.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.2174\/157488807779316973"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32831366eb"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705966"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.06.007"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2146"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.11.025"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704842"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-140095"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-78580-6_9"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.311"},{"key":"e_1_2_8_15_2","first-page":"635","volume-title":"Thomas' hematopoietic cell transplantation","author":"Sullivan KM","year":"2004"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705384"},{"key":"e_1_2_8_17_2","first-page":"747","article-title":"Long\u2010term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors","volume":"18","author":"Bishop MR","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_8_18_2","first-page":"320","article-title":"Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell depletion equivalent to elutriation","volume":"23","author":"Cottler\u2010Fox M","year":"1995","journal-title":"Exp Hematol"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401577"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1473"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(90)90071-V"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.03.005"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.0953"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2007.08.013"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.10.032"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702872"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.02.001"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810223391702"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-010-0113-4"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-211441"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.11.7085"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.12.705"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704342"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-001909"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2011.03478.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2011.03478.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T11:59:31Z","timestamp":1697284771000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2011.03478.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,10]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1111\/j.1537-2995.2011.03478.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2011.03478.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,10]]}}}